Schonfeld Strategic Advisors’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,210	Closed	-$7.99K	–	2570
2024 Q2	$7.99K	Sell	1,210 -1,710	-59%	-$11.6K	﹤0.01%	2018
2024 Q1	$32.1K	Sell	2,920 -950	-25%	-$10.3K	﹤0.01%	1911
2023 Q4	$52.2K	Sell	3,870 -240	-6%	-$3.89K	﹤0.01%	1666
2023 Q3	$89.2K	Buy	4,110 +30	+0.7%	+$962	﹤0.01%	1505
2023 Q2	$157K	Sell	4,080 -170	-4%	-$6K	﹤0.01%	1630
2023 Q1	$118K	Buy	+4,250	New	+$144K	﹤0.01%	1662
2021 Q4	–	Sell	-52	Closed	-$20K	–	2730
2021 Q3	$20K	Buy	+52	New	+$22.3K	﹤0.01%	2055
2021 Q1	–	Sell	-113	Closed	-$150K	–	2235
2020 Q4	$150K	Sell	113 -444	-80%	-$651K	﹤0.01%	1395
2020 Q3	$1.26M	Sell	557 -193	-26%	-$436K	0.02%	646
2020 Q2	$1.69M	Buy	+750	New	+$2.04M	0.04%	449

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Schonfeld Strategic Advisors's BIOR Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2024, closing a stake of 1,210 shares — an estimated $7.99K sold.

Schonfeld Strategic Advisors first reported a position in BIOR in Q2 2020 and held it in 10 quarters. The position peaked at $1.69M in Q2 2020. 20 funds tracked by Wall St. Rank hold BIOR as of Q3 2024.

Schonfeld Strategic Advisors reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Schonfeld Strategic Advisors sold 1,210 Biora Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $7.99K.
Schonfeld Strategic Advisors first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Schonfeld Strategic Advisors's Biora Therapeutics, Inc. Common Stock position peaked at $1.69M in Q2 2020.
20 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.